These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 9818656)
21. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [TBL] [Abstract][Full Text] [Related]
22. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396 [TBL] [Abstract][Full Text] [Related]
23. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Cid MC; Ercilla G; Vilaseca J; Sanmarti R; Villalta J; Ingelmo M; Urbano-Marquez A Arthritis Rheum; 1988 May; 31(5):678-82. PubMed ID: 3259885 [TBL] [Abstract][Full Text] [Related]
24. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. Weyand CM; Hicok KC; Hunder GG; Goronzy JJ J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092 [TBL] [Abstract][Full Text] [Related]
25. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. Calamia KT; Moore SB; Elveback LR; Hunder GG J Rheumatol; 1981; 8(6):993-6. PubMed ID: 6948960 [TBL] [Abstract][Full Text] [Related]
27. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. Amoli MM; Gonzalez-Gay MA; Zeggini E; Salway F; Garcia-Porrua C; Ollier WE J Rheumatol; 2004 Dec; 31(12):2413-7. PubMed ID: 15570643 [TBL] [Abstract][Full Text] [Related]
28. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460 [TBL] [Abstract][Full Text] [Related]
29. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor. Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795 [TBL] [Abstract][Full Text] [Related]
30. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445 [TBL] [Abstract][Full Text] [Related]
32. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Buc M; Bucová M; Javor J; Krivosíkova M; Stuchlíkova M; Shawkatova I; Michalková D; Barák L; Jancová E; Petrek M Endocr Regul; 2006 Mar; 40(1):1-6. PubMed ID: 16964961 [TBL] [Abstract][Full Text] [Related]
33. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520 [TBL] [Abstract][Full Text] [Related]
35. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis. Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889 [TBL] [Abstract][Full Text] [Related]
36. Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA J Rheumatol; 2001 Jul; 28(7):1600-4. PubMed ID: 11469468 [TBL] [Abstract][Full Text] [Related]
37. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088 [TBL] [Abstract][Full Text] [Related]
38. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171 [TBL] [Abstract][Full Text] [Related]